Search - tctmd.com

Displaying 121 - 140 of 172

Sort: Relevancy | Date

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

October 24, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Industry News

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

October 19, 2012

News Industry News

FDA Approval of Transapical Approach Offers Patients with Severe Aortic Stenosis a New Surgical Option

October 19, 2012

News Industry News

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

October 10, 2012

News Industry News

New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve System

October 02, 2012

News Industry News

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

September 05, 2012

News Industry News

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

July 18, 2012

News Industry News

FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients

June 13, 2012

News Industry News

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

May 15, 2012

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

April 23, 2012

News Industry News

St. Jude Medical Launches New Trifecta Heart Valve in Japan

April 17, 2012

News Industry News

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

April 09, 2012

News Industry News

Edwards Lifesciences Files Official Comment on CMS' Proposed TAVR National Coverage Determination

March 04, 2012

News Industry News

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial

January 23, 2012

News Industry News

St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve

December 12, 2011

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

News Industry News

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

November 09, 2011

News Industry News

Quality of life benefits of transcatheter aortic valve replacement differ by access site

November 09, 2011

Advertisement

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Study Confirms Benefits of Transcatheter Aortic Valve Replacement Over Three Years

FDA expands approved use of Sapien artificial heart valve

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

FDA Approval of Transapical Approach Offers Patients with Severe Aortic Stenosis a New Surgical Option

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve System

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus™ Aortic Valve System

St. Jude Medical Launches New Trifecta Heart Valve in Japan

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

Edwards Lifesciences Files Official Comment on CMS' Proposed TAVR National Coverage Determination

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial

St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study

Quality of life benefits of transcatheter aortic valve replacement differ by access site

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content